Kris Rogers is a Biostatistician with over 17 years of experience in health and medical research. He is an Associate Professor at the Graduate School of Health, University of Technology Sydney, Sydney, NSW, Australia. Kris has applied biostatistics to a range of areas in population health and clinical research.
Steven P. Djordjevic is a Professor of Infectious Disease and Group Leader at the Ithree Institute at the University of Technology Sydney, Sydney, NSW, Australia. He received his B.Sc. at the University of Queensland, Brisbane, Australia from 1980 to 1982 and his Ph.D. at the Australian National University, Canberra, Australia from 1984 to 1988. He is a co-founder and a member of the governing board and the scientific management committee of Ausgem, the Australian Centre for Genomic Epidemiological Microbiology, a collaborative partnership with the NSW Department of Primary Industries. His group also has a focus on the molecular, structural, and biochemical characterization of bacterial molecules that function in adherence, colonization, and invasion of eukaryote cells and a strong interest in the roles of protein processing and protein multifunctionality in bacterial pathogenesis.
Antoine M Van Oijen is a Professor and Associate Dean (Research) at the Faculty of Medicine and Health of the University of Sydney in Sydney, NSW, Australia. He has led research groups at Harvard Medical School (USA), Groningen University (the Netherlands), and the University of Wollongong (Australia). He was an ARC Laureate Fellow (2015–2020) and is currently an NHMRC Leadership Fellow (L2; 2021–2025). In Wollongong, he founded Molecular Horizons, a molecular life sciences institute, and led the establishment of major core facilities. At the University of Sydney, Professor van Oijen is responsible for the Faculty of Medicine and Health's research portfolio and for achieving its strategic and operational objectives. His primary research interests revolve around DNA replication and repair, with a focus on developing imaging approaches and integrating these with molecular biophysical approaches to understand how microbial systems copy and maintain DNA.
A/Prof. Caitlin Keighley is a Microbiologist and Infectious Diseases Physician with interests that include obstetrics and the immunocompromised host. She holds a clinical adjunct appointment at The University of Wollongong. She joined Southern.IML Pathology after having worked at Westmead, St George, Royal Prince Alfred, Alice Springs and Canberra Hospitals. A/Prof. Keighley has also worked with the Queensland Institute of Medical Research. Dr. Keighley has published numerous articles in mycology, antenatal infections and antimicrobial resistance, has been active in quality improvement activities, and has held various teaching positions. She is a contributor to the Wollongong Antimicrobial Resistance Research Alliance (WARRA).
Katja Taxis is a full Professor of Pharmacotherapy and Clinical Pharmacy at the University of Groningen. She has a degree in pharmacy from the University of Hamburg and an M.Sc. and Ph.D. from the School of Pharmacy, University College London (UCL). She worked as a researcher and lecturer at the University of Tübingen before joining the University of Groningen in 2004. She is also the Programme Director of the Bachelor and Master of Science in Pharmacy. In addition, she is the Past Chair of EuroDURG (European Drug Utilization Research Group) and a Board Member of PAO Farmacie.
Dr. Hamish Robertson is a health and medical geographer with 20 years of experience in population aging and aged care. He is a Senior Lecturer at the Faculty of Health of Queensland University of Technology and a Visiting Scholar at Aston University. He earned his Ph.D. from the University of New South Wales in 2017. He has experience in several related fields such as multicultural health, disability, and diversity work.
Lisa G Pont is a Professor at the Graduate School of Health, University of Technology Sydney, Sydney, NSW, Australia. She received her B.Sc. at the University of Newcastle Australia, Newcastle, Australia and her Ph.D. at the University of Groningen, Groningen, The Netherlands. She is a Fellow of the International Society for Pharmacoepidemiology (ISPE) and was elected to the ISPE Board of Directors in 2016. She was the first Australian to lead an ISPE Special Interest Group, leading the Drug Utilisation and Health Services Research Group from 2012–2015. She worked with the World Health Organisation in 2002 and 2016 as an invited member of the Global Medication Safety Initiative team.
